Sijmen de Vries
Directeur Général chez PHARMING GROUP N.V.
Fortune : 8 M $ au 30/04/2024
Profil
Sijmen de Vries is currently the Chief Executive Officer & Executive Director at Pharming Group NV.
He is also the Chief Executive Officer at Pharming Intellectual Property BV and a Non-Executive Director at Sylus Pharmaceuticals Ltd.
Additionally, he serves as an Independent Non-Executive Director at Biodexa Pharmaceuticals Plc and as a Finish Partner at BioConnection BV.
In his former positions, Dr. de Vries was the Chief Executive Officer at Morphochem AG and 4-Antibody AG.
He also served as a Non-Executive Director at Midatech Ltd.
from 2004 to 2015.
Dr. de Vries holds a doctorate degree from the University of Amsterdam and an MBA from Ashridge Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARMING GROUP NV
1,27% | 31/03/2024 | 8 544 736 ( 1,27% ) | 8 M $ | 30/04/2024 |
| 17/04/2023 | 1 322 ( 0,00% ) | 0 $ | 31/01/2024 |
Postes actifs de Sijmen de Vries
| Sociétés | Poste | Début |
|---|---|---|
| PHARMING GROUP N.V. | Directeur Général | 13/10/2008 |
| BIODEXA PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 13/11/2014 |
| Sylus Pharmaceuticals Ltd. | Directeur/Membre du Conseil | 21/06/2010 |
Pharming Intellectual Property BV
 Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Directeur Général | - |
BioConnection BV
 BioConnection BV BiotechnologyHealth Technology BioConnection BV manufactures and develops injectable pharmaceutical products. Its services include fill & finish, freeze drying, clinical trial material services, project management and consultancy services. The company was founded in 2005 and is headquartered in Oss, the Netherlands. | Corporate Officer/Principal | - |
Anciens postes connus de Sijmen de Vries
| Sociétés | Poste | Fin |
|---|---|---|
Midatech Ltd.
 Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom. | Directeur/Membre du Conseil | 13/03/2015 |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Directeur Général | - |
Morphochem AG
 Morphochem AG Miscellaneous Commercial ServicesCommercial Services Morphochem AG discovers and develops drugs. It focuses on finding therapeutic agents to treat cancer, anti-infectives, inflammation, metabolic disorders and infectious diseases, with particular emphasis on enzyme inhibitors. The company has developed an integrated chemical genomics drug discovery engine that it is applying in third party research programs and for building its own fully owned pipeline. Morphochem is headquartered in Munich, Germany. | Directeur Général | - |
Formation de Sijmen de Vries
| University of Amsterdam | Doctorate Degree |
| Ashridge Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 6 |
|---|---|
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Morphochem AG discovers and develops drugs. It focuses on finding therapeutic agents to treat cancer, anti-infectives, inflammation, metabolic disorders and infectious diseases, with particular emphasis on enzyme inhibitors. The company has developed an integrated chemical genomics drug discovery engine that it is applying in third party research programs and for building its own fully owned pipeline. Morphochem is headquartered in Munich, Germany. | Commercial Services |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Health Technology |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology BioConnection BV manufactures and develops injectable pharmaceutical products. Its services include fill & finish, freeze drying, clinical trial material services, project management and consultancy services. The company was founded in 2005 and is headquartered in Oss, the Netherlands. | Health Technology |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom. | Health Technology |
| Sylus Pharmaceuticals Ltd. | |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Producer Manufacturing |
